QDIS Blog

A blog about chemistry, drug development, science, and technology

May 21, 2007

Cell Therapeutics to pay $10.5 million

by @ 7:46 pm.  Filed under Pharma News

Seems my old company is now paying $10.5 million to resolve claims that they were promoting Trisenox for uses that were not approved.

Cell Therapeutics to pay $10.5 million:

I always thought they were leaving them selves open for this sort of problems back when I was working for them given the huge amount of off-label use. When a huge portion of your drug is being used for diseases it isn’t approved for, you are going to raise some eyebrows.

I should note that “Cell Therapeutics does not admit any wrongdoing in the matter”. And we all know what that really means.

Technorati Tags:

Email Ed Vawter



Related Posts:
  • GlaxoSmithKline To Acquire Domantis
  • AstraZeneca to buy Arrow Therapeutics
  • Follow up on Advanced Cell Technology Inc
  • Journal Nature will clarify human embryo study
  • Technology and Manners

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    Leave a Reply

    [powered by WordPress.]

    QDIS: blogging about chemistry, drug development, science and technology.

    Internal Links

    Categories

    Search This Blog

    Archives

    May 2007
    S M T W T F S
    « Apr   Jun »
     12345
    6789101112
    13141516171819
    20212223242526
    2728293031  

    Search Entire Site

    Subscribe (It's Free!)

    Performancing

    Chemistry, science, and technology for the future.

    logo2

    General Links

    Blog Links

    Chemistry Journal Feeds

    Chemistry Feeds

    35 queries. 1.016 seconds